In PBMCs from T2DM patients, the expression of IL-12, CCR7, ABCA1, and SR-A1 was increased, whereas the expression of CXCL10, CCL17, ABCG1, 27-hydroxylase, A2AR and A3R was decreased. Here, CCL17 is linked to type 2 diabetes mellitus.